Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday – The Motley Fool

  1. Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday  The Motley Fool
  2. Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance | Eli Lilly and Company  Investors | Eli Lilly and Company
  3. Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz  CNBC
  4. Eli Lilly Stock Slides. Zepbound and Mounjaro Sales Miss Estimates Again.  Barron’s
  5. Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow  Investor’s Business Daily